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Structurally simple 1-thio-𝛽-D-glucopyranosides were synthesized and tested as potential inhibitors toward several fungal
glycosidases from Aspergillus oryzae and Penicillium canescens. Significant selective inhibition was observed for 𝛼- and 𝛽-
glucosidases, while a weak to moderate activation for 𝛼- and 𝛽-galactosidases.
1. Introduction
Thioglycosides are the hydrolysis- and metabolism-resistant
synthetic S-analogs of natural O-glycosides. They attracted
recently a rapidly increasing attention as competitive
inhibitors of glycosidases and other enzymes involved in a
variety of biochemical processes [1, 2] related in particular to
metabolic disorders and diseases, such as diabetes [1, 3], to
inflammations [2, 4] and viral or bacterial infections [5–17],
including tuberculosis [9, 10], and to cancer [2, 18–20].
However, surprisingly little is known about the inhibition
of glucosidases by 1-thio-𝛽-D-glucosides so far [21–24] (see
the discussion). In a search for simple, readily accessible,
and efficient glycosidase inhibitors [25–27], we designed,
prepared, and assayed a series of structurally simple 1-thio-
𝛽-D-glucosides.
2. Results and Discussion
2.1. Synthesis of 1-Thio-𝛽-D-glucopyranosides. A series of
aryl and alkyl 1-thio-𝛽-D-glucopyranosides 2a–2i was syn-
thesized according to Scheme 1. In addition to the model
compounds 2a–2f with simple aryl and alkyl aglycones,
we included the phenanthroline derivative 2g, which was
found to possess activity towards some glycosidases [27].
Compounds 2h–2i were designed as disaccharide analogues
in view of the significant inhibitory activity of the 1,2-
cyclohexanedicarboxylic acid derivatives towards fungal gly-
cosidases [25, 26].
The structures of all products and intermediates were
determined from the data of 1H NMR and 13C NMR,
including COSY and HMQC techniques. Thanks to a bias of
the conformational equilibria towards the all-equatorial form
of the pyranose ring, the configurational assignment was
rather straightforward: large spin-spin coupling constants
(9–11Hz) indicated a trans-diaxial orientation of the corre-
sponding vicinal protons, while all other relative positions
(axial-equatorial and equatorial-equatorial) resulted in small
couplings between them (2–4Hz).
2.2. Glycosidase Inhibitory Activity. The synthesized com-
pounds have been assayed for enzyme inhibitory activ-
ity against several glycosidases in multienzyme complexes
isolated from fungi Penicillium canescens and Aspergillus
oryzae [28–32]. The multienzyme complex from P. canescens
contains 𝛼-D- and 𝛽-D-galactosidase, 𝛽-D-glucosidase, and
𝛼-L- and 𝛽-D-fucosidase [28–31]. The multienzyme complex
from A. oryzae contains 𝛼-D- and 𝛽-D-galactosidase, 𝛼-
D- and 𝛽-D-glucosidase, and 𝛼-L- and 𝛽-D-fucosidase [32].
All assays have been performed in a standard way [33] by
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Scheme 1: Preparation of 1-thio-𝛽-D-glucopyranosides 2a–2i.
monitoring spectrophotometrically at 400 nm the release of
p-nitrophenol from the corresponding p-nitrophenyl gly-
cosides. The inhibitory activity of studied compounds was
found to depend on the structure of inhibitor, the type of
enzyme, and the particular source of enzyme.
Usually, the structural analogues of carbohydrates with
certain configuration are expected to influence activity of
the corresponding enzymes (“like inhibits like”). Thus, 4-
nitrophenyl 1-thio-𝛽-D-glucoside was used to study binding
to 𝛽-D-glucosidase from barley and rice and was shown to be
a competitive inhibitor [22]. As another example, a series of
alkyl/aryl 1-thio-𝛽-D-galactosides was designed and studied
as inhibitors of 𝛽-D-galactosidase from E. coli [17]. Similarly,
we tried the 1-thio-𝛽-D-glucosides 2a–2i first of all as possible
inhibitors against 𝛽-D-glucosidases. In the preliminary tests,
all studied compounds demonstrated indeed a substantial
inhibitory activity toward fungal𝛽-D-glucosidases fromboth
P. canescens and A. oryzae strains (Figures 1 and 2). It is
worth mentioning that compounds 2a–2f were 10-fold more
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Figure 1: Effect of 1-thio-𝛽-D-glucopyranosides (1mM) on the
activity of A. oryzae glycosidases.
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Figure 2: Effect of 1-thio-𝛽-D-glucopyranosides (1mM) on the
activity of P. canescens glycosidases.
potent in the case of 𝛽-D-glucosidase from A. oryzae than
methyldeoxynojirimycin at 85% inhibition [34].
It was found previously that the inhibitors of 𝛽-
D-glucosidase may also possess the 𝛼-D-glucosidase
inhibitory activity [25, 26, 35]. For example, N-substituted
aminomethyl-𝛽-D-glucopyranosides inhibited yeast and rat
intestinal 𝛼-D-glucosidases [35]. In this study, compounds
2a–2h showed only weak inhibition of 𝛼-D-glucosidase from
A. oryzae (Figure 1).
Quite unusually, 1-thio-𝛽-D-glucosides revealed a weak
to moderate ability to activate 𝛼- and 𝛽-D-galactosidases
(Figures 1 and 2), especially 𝛼-D-galactosidase from P.
canescens (Figure 2). The strongest activation was observed
in the case of phenanthrolyl-1-thio-𝛽-D-glucoside 2g (Fig-
ures 1 and 2). Some derivatives of 1,10-phenanthroline were
found earlier to activate 𝛽-D-galactosidases, while other
derivatives acted as inhibitors [27]. Towards the fungal
𝛽-D-glucosidases, all 1,10-phenanthrolines were activators,
with exception of thioglucoside 2g, which was an inhibitor
International Journal of Carbohydrate Chemistry 3
Table 1: Inhibition of 𝛽-D-glucosidases at pH 4.2 and 30∘C.
Inhibitor (R)
𝛽-D-Glucosidase 𝛽-D-Glucosidase
A. oryzae P. canescens
𝐾
𝑖
, 𝜇M 𝐾
𝑖
, 𝜇M
2a (Ph)a 129 4.02
2b (p-ClC6H4) 183 5.56
2c (p-MeC6H4) 218 11.1
2d (2󸀠-naphthyl) 159 4.53
2e (PhCH2) 109 6.32
2f (n-C6H13) 80.7 3.45
2g (5󸀠-phen) 91.7 2.84
2h (diester) 223 12.3
2i (diacid) 1500 27.5
a
𝐾𝑖 = 1530 𝜇M (for 𝛽-D-glucosidase from fungus Stachybotrys atra) [21].
[27]. Noteworthy, the nitrogen analog of 2g, N-(1,10-
phenanthrolin-5-yl)-𝛽-D-glucopyranosylamine was recently
synthesized, but no data on enzyme inhibition or activation
were obtained yet [36]. The mechanism of activation is
currently unknown. It may be a result of an allosteric effect
in these enzymes [37] or of a change in their hydration [38].
The activation of 𝛼/𝛽-D-galactosidases may be interesting
for treatment of certain diseases and merits further studies
[37, 38].
The analysis of the Lineweaver-Burk plots indicated that
compounds 2a–2i inhibited the 𝛽-D-glucosidases competi-
tively. Their inhibition parameters are presented in Table 1.
The values of𝐾
𝑖
are systematically larger for the enzyme from
A. oryzae as compared to P. canescens (by factors 32–35 for
2a, 2b, 2d, and 2g; and by factors 17–20 for 2c, 2e, 2f, and
2h). Similar ratios were obtained earlier for the inhibition of
these enzymes by derivatives of cyclohexane-1,2-dicarboxylic
acids [25]. This is apparently due to structural differences of
the enzymes, which result also in different values ofMichaelis
constant: 𝐾
𝑀
= 500 𝜇M (A. oryzae) and 𝐾
𝑀
= 40 𝜇M (P.
canescens) [25]. Interestingly, higher values of𝐾
𝑀
were found
also for 𝛽-D-galactosidase from A. oryzae as compared to
enzyme from P. canescens [39].
The previously available data on 1-thio-𝛽-D-gluco-
pyranosides as glycosidase inhibitors were limited to the
derivatives with the following aglycones: phenyl (2a), 𝐾
𝑖
=
1530 𝜇M (Stachybotrys atra) [21]; 4-nitrophenyl, 𝐾
𝑖
=
664 𝜇M (rice) and 𝐾
𝑖
= 95 𝜇M (barley) [22]; benzo-
1,4-quinone, 𝐾
𝑖
= 60 𝜇M (A. faecalis); chlorobenzo-1,4-
quinone,𝐾
𝑖
= 400 𝜇M(A. faecalis) [23]; and 2-(3-methyl-3H-
diazirine-3-yl)-ethyl, 𝐾
𝑖
= 1500 𝜇M (sweet almond) [24].
Although thioglycosides are usually resistant to hydrolysis,
it was found also that with some specific aglycones they
may be hydrolysable and can serve as glycosidase substrates
[40]. It is interesting to compare our results (Table 1) to
the data for some known inhibitors of 𝛽-D-glucosidases:
1-deoxynojirimycin, 𝐾
𝑖
= 0.3–2.7 𝜇M (Aspergillus wentii);
𝐾
𝑖
= 12 𝜇M (Agrobacterium faecalis); N-methyl-1-deox-
ynojirimycin, 𝐾
𝑖
= 43 𝜇M (sweet almond); and N-hexyl-
1-deoxynojirimycin, 𝐾
𝑖
= 200 𝜇M (calf liver cytosolic)
and 𝐾
𝑖
= 69 𝜇M (calf spleen lysosomal) [41]. From this
comparison, compounds 2a–2h are moderately strong 𝛽-D-
glucosidase inhibitors.
The comparison of thioglucosides 2a–2i allows a pre-
liminary elucidation of the effect of aglycon upon their
inhibitory activity. It is known that the presence of alkyl
groups and other lipophilic moieties often increases the
efficiency of glycosidase inhibitors. This effect, mostly
towards 𝛽-glucosidases, was observed for derivatives of 1-
deoxynojirimycin and other iminosugars, alkyl glycosides,
carbasugars, and some other inhibitors. It was explained
by additional stabilization of the alkyl chains or aromatic
residues by the hydrophobic pocket or cleft within or in
vicinity of the enzymebinding site (for the detailed discussion
see [25, 42, 43] and references therein; in addition see [37, 44,
45]). The results of our study (Table 1) seem to confirm the
general regularities observed earlier. Thus, the most potent
inhibitors of 𝛽-D-glucosidases, compounds 2f and 2g, have
large lipophilic aglycones, while the thioglucoside 2iwith the
most polar aglycone in this series shows almost negligible
inhibition. However, the dependence of inhibition on the
aglycone’s lipophilicity is not straightforward: despite their
large aromatic aglycones, the thioglucosides 2a–2e produced
much weaker inhibition than 2f and 2 g (see also discussion
in [25]). The influence of the aglycone shape remains also
uncertain.The best results were achieved both for the narrow
alkyl chain (2f) and for the wide polyaromatic moiety (2g).
3. Experimental Section
The chemicals used in this study were purchased from com-
mercial sources (Sigma-Aldrich, TCI, and Across Organics)
and used without additional purification. All solvents were
purified by conventional techniques prior to use. Column
chromatography was performed on silica gel (40–75𝜇m,
Sorbent Technologies) and aluminum oxide (activated basic,
58A˚, Aldrich). The reactions were monitored by TLC on
silica gel plates, Analtech Inc (visualization by staining with
sulfuric acid followed by heating or with I
2
).
1H NMR and 13C NMR spectra were acquired on JEOL
ECA-600 NMR-spectrometer (600MHz for 1H and 150MHz
for 13C) with spinning at rt. 1H-1H-COSY and 1H-13C-
HMQC techniques were used to assign the signals. High
resolution mass spectra (HRMS) were obtained on a JEOL
AccuTOF time-of-flight mass spectrometer (Peabody, MA)
coupled with an Ionsense DART open-air ionization source
(Saugus,MA).The instrumentwas tuned to a resolving power
of 7,000 with reserpine directly infused into the electrospray
ionization source; this provided a stable ion current to tune
the time-of-flight parameters. Samples were introduced into
the DART sample gap with a glass melting point capillary by
first dipping the closed end of the capillary into the sample
then immediately placing it into the heliummetastable beam.
The helium gas temperature was set to 250∘C to aid in the
desorption of the analyte from the capillary.The samples were
held in the sample gap for 10–15 seconds to acquire several
mass spectra to average for an accurate m/z assignment.
Optical rotation was measured for solutions in a 5 cm cell
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with an automatic polarimeter Autopol I. A Beckman Du-65
spectrometer was used for the enzymatic hydrolysis studies.
3.1. General Procedure for the Synthesis of 1-Thio-𝛽-D-gluco-
pyranoside Tetraacetates (Adapted from [46]). 𝛼-D-Glucose
pentaacetate (0.5–2.1 g and 1.3–5.3mmol) was dissolved in
CH
2
Cl
2
(25mL), followed by addition of a thiol (1.5mol
eq). The reaction mixture was stirred for 10 minutes in an
ice bath. Then BF
3
⋅Et
2
O (3mol eq) was added slowly, and
the mixture was allowed to come to room temperature and
was stirred with gentle reflux overnight. The solvent was
removed by evaporation and product was isolated by column
chromatography (silica gel, hexane/EtOAc 5 : 1).
3.1.1. Phenyl-1-thio-𝛽-D-glucopyranoside Tetraacetate (1a).
The stirring overnight was done without reflux. Yield 1.01 g
(45%) from 2.00 g (5.1mmol) 𝛼-D-glucose pentaacetate. 1H
NMR (CDCl
3
): 𝛿 2.00 (s, CH
3
), 2.02 (s, CH
3
), 2.087 (s, CH
3
),
2.094 (s, CH
3
), 3.73 (ddd, J = 2.5, 5.1, 10.0Hz; H5), 4.18 (dd,
J = 2.5, 12.2Hz; H6), 4.23 (dd, J = 5.1, 12.2Hz; H6), 4.71 (d,
J = 10.1 Hz; H1), 4.98 (dd, J = 9.3, 10.1 Hz; H2), 5.05 (dd,
J = 9.6, 10.0Hz; H4), 5.23 (t, J = 9.4Hz; H3), 7.31–7.35 (m,
3H; Ph), 7.50 (m, 2H; Ph). 13C NMR (CDCl
3
): 20.60, 20.75
(CH
3
, Ac), 62.09 (C6), 68.10 (C4), 69.86 (C2), 73.91 (C3),
75.74 (C5), 85.71 (C1), 128.41, 128.92, 131.59, 133.10 (Ph), 169.26,
169.40, 170.18, 170.58 (C=O); (Lit. 1H, 13CNMR [47]). HRMS:
C
20
H
24
O
9
S requires m/z [M+NH
4
]+ 458.1485; observed
m/z 458.1468.
3.1.2. p-Chlorophenyl-1-thio-𝛽-D-glucopyranoside Tetraacet-
ate ( 1b). Yield 0.97 g (39%) from 2.07 g (5.3mmol) 𝛼-D-
glucose pentaacetate. 1HNMR (CDCl
3
): 𝛿 1.99 (s, CH
3
), 2.02
(s, CH
3
), 2.09 (s, CH
3
), 2.10 (s, CH
3
), 3.72 (ddd, J = 2.6, 4.9,
10.1 Hz; H5), 4.18 (dd, J = 2.6, 12.3Hz; H6), 4.22 (dd, J =
4.9, 12.3Hz; H6), 4.65 (d, J = 10.1 Hz; H1), 4.94 (dd, J = 9.4,
10.1 Hz; H2), 5.02 (t, J = 9.8Hz; H4), 5.22 (t, J = 9.4Hz; H3),
7.30 (m, 2H; Ar), 7.44 (m, 2H; Ar). 13C NMR (CDCl
3
): 20.56,
20.72 (CH
3
, Ac), 61.96 (C6), 67.99 (C4), 69.71 (C2), 73.79
(C3), 75.81 (C5), 85.16 (C1), 129.04, 129.38, 134.97 (Ar), 169.21,
169.35, 170.13, 170.51 (C=O); (Lit. 1H, 13CNMR [47]). HRMS:
C
20
H
23
ClO
9
S requires m/z [M+NH
4
]+ 492.1095; observed
m/z 492.1062.
3.1.3. p-Tolyl-1-thio-𝛽-D-glucopyranoside Tetraacetate (1c).
Yield 1.75 g (71%) from 2.05 g (5.3mmol) 𝛼-D-glucose pen-
taacetate. 1H NMR (CDCl
3
): 𝛿 1.99 (s, CH
3
), 2.02 (s, CH
3
),
2.09 (s, CH
3
), 2.10 (s, CH
3
), 2.35 (s, CH
3
, p-tolyl), 3.70 (ddd,
J = 2.6, 4.9, 10.1 Hz; H5), 4.18 (dd, J = 2.6, 12.2Hz; H6), 4.22
(dd, J = 4.9, 12.2Hz; H6), 4.64 (d, J = 10.1 Hz; H1), 4.94 (dd,
J = 9.4, 10.0Hz; H2), 5.03 (t, J = 9.8Hz; H4), 5.21 (t, J =
9.4Hz; H3), 7.13 (d, J = 7.8Hz, 2H; Ar), 7.39 (d, J = 8.0Hz,
2H; Ar). 13C NMR (CDCl
3
): 20.68, 20.70, 20.85, 20.87 (CH
3
,
Ac), 21.29 (CH
3
, p-tolyl), 62.08 (C6), 68.12 (C4), 69.85 (C2),
73.97 (C3), 75.69 (C5), 85.79 (C1), 127.49, 129.65, 133.81, 138.79
(Ar), 169.23, 169.38, 170.19, 170.58 (C=O); (Lit. 1H, 13C NMR
[47]). HRMS: C
21
H
26
O
9
S requires m/z [M+NH
4
]+ 472.1641;
observedm/z 472.1590.
3.1.4. (2-Naphthyl)-1-thio-𝛽-D-glucopyranoside Tetraacetate
(1d). Yield 0.23 g (37%) from 0.50 g (1.3mmol) 𝛼-D-glucose
pentaacetate dissolved in 10mL CH
2
Cl
2
. 1H NMR (CDCl
3
):
𝛿 1.99 (s, CH
3
), 2.02 (s, CH
3
), 2.04 (s, CH
3
), 2.12 (s, CH
3
), 3.74
(ddd, J = 2.4, 5.1, 10.1 Hz; H5), 4.18 (dd, J = 2.4, 12.2Hz; H6),
4.24 (dd, J = 5.2, 12.3Hz; H6), 4.79 (d, J = 10.1 Hz; H1), 5.02
(dd, J = 9.3, 10.0Hz; H2), 5.05 (dd, J = 9.5, 10.0Hz; H4), 5.24
(t, J = 9.4Hz; H3), 7.51 (m, 2H; Ar), 7.56 (dd, J = 1.8, 8.6Hz,
1H; Ar), 7.79 (d, J = 8.5Hz, 1H; Ar), 7.82 (m, 2H; Ar), 8.00
(d, J = 1.7Hz, 1H; Ar). 13CNMR (CDCl
3
): 20.58, 20.70, 20.79
(CH
3
, Ac), 62.10 (C6), 68.14 (C4), 69.98 (C2), 73.92 (C3),
75.82 (C5), 85.80 (C1), 126.65, 126.75, 127.68, 128.46, 128.70,
130.19, 132.74, 132.84, 133.39 (Ar), 169.29, 169.36, 170.18, 170.59
(C=O); (Lit. 1H, 13CNMR [47]). HRMS: C
24
H
26
O
9
S requires
m/z [M+NH
4
]+ 508.1641; observedm/z 508.1583.
3.1.5. Benzyl-1-thio-𝛽-D-glucopyranoside Tetraacetate (1e).
Yield 1.09 g (46%) from 2.05 g (5.3mmol) 𝛼-D-glucose pen-
taacetate. 1H NMR (CDCl
3
): 𝛿 1.99 (s, CH
3
), 2.01 (s, CH
3
),
2.02 (s, CH
3
), 2.12 (s, CH
3
), 3.57 (ddd, J = 2.3, 5.1, 10.0Hz;
H5), 3.81 (d, J = 12.9Hz, 1H; CH
2
Ph), 3.91 (d, J = 12.9Hz, 1H;
CH
2
Ph) 4.11 (dd, J = 2.3, 12.4Hz;H6), 4.21 (dd, J = 5.1, 12.4Hz;
H6), 4.26 (d, J = 10.0Hz; H1), 5.04 (dd, J = 9.3, 10.0Hz; H2),
5.05 (dd, J = 9.3, 10.0Hz; H4), 5.11 (t, J = 9.3Hz; H3), 7.27–
7.34 (m, 5H; Ph). 13C NMR (CDCl
3
): 20.56, 20.58, 20.64,
20.76 (CH
3
, Ac), 33.77 (CH
2
Ph), 62.18 (C6), 68.31 (C4), 69.74
(C2), 73.78 (C3), 75.76 (C5), 81.89 (C1), 127.41, 128.59, 129.04,
136.76 (Ph), 169.40, 170.18, 170.63 (C=O); (Lit. 1H, 13C NMR
[47]). HRMS: C
21
H
26
O
9
S requires m/z [M+NH
4
]+ 472.1641;
observedm/z 472.1596.
3.2. General Procedure for the Synthesis of 1-Thio-𝛽-D-
glucopyranosides (Adapted from [46]). The respective 1-thio-
𝛽-D-glucopyranoside tetraacetate 1a–1e (100mg) was mixed
with MeOH (2mL) in a 5mL flask. The freshly prepared
MeONa solution was added slowly until the pH of the
mixture was 9-10 as measured by pH paper. The reaction
mixture was allowed to stir until all starting tetraacetate was
consumed (TLC; silica gel, hexane/EtOAc 5 : 1). The basic
solution was then neutralized with Dowex 50W X8 ion
exchange resin, filtered, and evaporated to yield 95–99% of
pure thioglucoside.
3.2.1. Phenyl-1-thio-𝛽-D-glucopyranoside (2a). 100mg (0.227
mmol) 1a yielded 60mg (97%) 2a as a white solid, mp 131–
133∘C (Lit. 113∘C [48]). 1H NMR (CD
3
OD): 𝛿 3.21 (dd, J =
8.8, 9.8Hz; H2), 3.28 (m, J = 8.5Hz; H3), 3.32 (ddd, J = 2.3,
5.7, 9.7Hz; H5), 3.38 (t, J = 8.6Hz; H4), 3.66 (dd, J = 5.5,
12.1 Hz; H6), 3.86 (dd, J = 2.1, 12.1 Hz; H6), 4.59 (d, J = 9.8Hz;
H1), 7.22 (m, 1H; Ph), 7.29 (m, 2H; Ph), 7.55 (m, 2H; Ph).
13CNMR (CD
3
OD): 62.85 (C6), 71.32 (C4), 73.75 (C2), 79.68
(C3), 82.04 (C5), 89.41 (C1), 128.29, 129.87, 132.66, 135.32 (Ph);
(Lit. 1H, 13C NMR [48]). HRMS: C
12
H
16
O
5
S requires m/z
[M+NH
4
]+ 290.1062; observedm/z 290.0993.
3.2.2. p-Chlorophenyl-1-thio-𝛽-D-glucopyranoside (2b). 100
mg (0.21mmol) 1b yielded 61mg (94%) 2b as a white solid,
mp 169.5–171.5∘C (Lit. 172–175∘C [49]). 1H NMR (CD
3
OD):
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𝛿 3.16 (dd, J = 8.8, 9.7Hz; H2), 3.25 (dd, J = 8.9, 9.6Hz; H3),
3.32 (ddd, J = 2.2, 5.7, 9.7Hz; H5), 3.35 (t, J = 8.7Hz; H4),
3.63 (dd, J = 5.7, 12.1 Hz; H6), 3.85 (dd, J = 2.1, 12.1 Hz; H6),
4.55 (d, J = 9.8Hz; H1), 7.28 (m, 2H; Ar), 7.52 (m, 2H; Ar).
13C NMR (CD
3
OD): 62.81 (C6), 71.29(C4), 73.67 (C2), 79.63
(C3), 82.10 (C5), 89.11 (C1), 129.88, 134.04, 134.28, 134.41 (C,
Ar). HRMS: C
12
H
15
ClO
5
S requiresm/z [M+NH
4
]+ 324.0673;
observedm/z 324.0619.
3.2.3. p-Tolyl-1-thio-𝛽-D-glucopyranoside (2c). 100mg (0.22
mmol) 1c yielded 62mg (98%) 2c as a white solid, mp 139.5–
142∘C (Lit. 148∘C [48]). 1H NMR (CD
3
OD): 𝛿 2.30 (s, CH
3
),
3.16 (dd, J = 8.8, 9.7Hz;H2), 3.25 (t, J = 9.8Hz;H3), 3.28 (ddd,
J = 2.1, 5.5, 9.6Hz; H5), 3.35 (t, J = 8.6Hz; H4), 3.64 (dd, J
= 5.4, 12.1 Hz; H6), 3.84 (dd, J = 1.9, 12.0Hz; H6), 4.50 (d, J
= 9.8Hz; H1), 7.11 (m, 2H; Ar), 7.45 (m, 2H; Ar). 13C NMR
(CD
3
OD): 21.10 (CH
3
), 62.87 (C6), 71.35 (C4), 73.70 (C2),
79.68 (C3), 81.96 (C5), 89.64 (C1), 130.53, 131.21, 133.48, 138.74
(C, Ar); (Lit. 1H, 13CNMR [48]). HRMS: C
13
H
18
O
5
S requires
m/z [M+NH
4
]+ 304.1219; observedm/z 304.1214.
3.2.4. (2-Naphthyl)-1-thio-𝛽-D-glucopyranoside (2d). 100mg
(0.20mmol) 1d yielded 62mg (94%) 2d as a white solid, mp
122–123.5∘C (Lit. 117–125∘C [50]). 1H NMR (CD
3
OD): 𝛿 3.26
(dd, J = 9.8, 8.8Hz; H2), 3.29 (m, H3), 3.32 (ddd, J = 2.3, 6.0,
9.8Hz; H5), 3.38 (t, J = 8.9Hz; H4), 3.66 (dd, J = 6.0, 12.1 Hz;
H6), 3.86 (dd, J = 2.2, 12.1 Hz; H6), 4.71 (d, J = 9.8Hz; H1),
7.45 (m, 2H; Ar), 7.63 (m, 1H; Ar), 7.79 (m, 3H; Ar), 8.07 (m,
1H; Ar). 13C NMR (CD
3
OD): 62.89 (C6), 71.39 (C4), 73.82
(C2), 79.70 (C3), 82.16 (C5), 89.37 (C1), 127.18, 127.52, 128.53,
128.65, 129.23, 130.13, 131.16, 132.75, 133.81, 135.14 (Ar). HRMS:
C
16
H
18
O
5
S requires m/z [M+NH
4
]+ 340.1219; observed m/z
340.1218.
3.2.5. Benzyl-1-thio-𝛽-D-glucopyranoside (2e). 100mg (0.22
mmol) 1c yielded 61mg (97%) 2c as a clear oil. 1H NMR
(CD
3
OD): 𝛿 3.19–3.29 (m, 4H; H2+H3+H4+H5), 3.67 (dd,
J = 6.2, 12.1 Hz; H6), 3.85 (d, J = 12.7Hz, 1H; CH
2
Ph), 3.89
(dd, J = 2.2, 12.1 Hz; H6), 4.03 (d, J = 12.7Hz, 1H; CH
2
Ph),
4.17 (d, J = 9.3Hz; H1), 7.22 (t, J = 7.4Hz, 1H; Ph), 7.29 (t, J =
7.3Hz, 2H; Ph), 7.37 (m, 2H; Ph). 13C NMR (CD
3
OD): 32.98
(CH
2
Ph), 61.67 (C6), 70.27 (C4), 73.02 (C2), 78.35(C3), 80.68
(C5), 83.78 (C1), 126.66, 128.11, 128.97, 138.10 (Ph); (Lit. 1H,
13C NMR [17]). HRMS: C
13
H
18
O
5
S requiresm/z [M+NH
4
]+
304.1219; observedm/z 304.1202.
3.3. Hexyl-1-thio-𝛽-D-glucopyranoside (2f). 1-Thio-𝛽-D-glu-
copyranose sodium salt 3 (100mg, 0.46mmol) was mixed
with methanol (2mL) followed by the addition of bromohex-
ane (75 𝜇L, 0.6mmol). The reaction mixture was stirred at
room temperature overnight and then evaporated in vacuo,
and the resulting white paste was rinsed with hexane and
then redissolved in methanol. The resulting suspension was
filtered, and the filtrate evaporated to yield clear oil 2f (98mg,
76%). 1H NMR (CD
3
OD): 𝛿 0.90 (t, J = 11.4Hz, 3H; CH
3
)
1.31 (m, 4H; CH
2
), 1.40 (m, 2H; CH
2
), 1.62 (m, 2H; CH
2
),
2.68 (dt, J = 12.5, 7.5Hz, 1H; SCH
2
), 2.73 (dt, J = 12.4, 7.3Hz,
1H; SCH
2
), 3.18 (dd, J = 8.7, 9.7Hz; H2), 3.25 (ddd, J = 2.1,
5.5, 9.5Hz; H5), 3.29 (m, H3), 3.33 (t, J = 8.9Hz; H4), 3.64
(dd, J = 5.5, 12.0Hz; H6), 3.84 (dd, J = 2.2, 12.0Hz; H6), 4.33
(d, J = 9.8Hz; H1). 13C NMR (CD
3
OD): 13.05 (CH
3
), 22.30
(CH
2
), 28.36 (CH
2
), 29.52 (CH
2
), 29.68 (CH
2
), 31.26 (CH
2
),
61.58 (C6), 70.17 (C4), 73.06 (C2), 78.27 (C3), 80.79 (C5), 85.81
(C1); (Lit. 1H, 13C NMR [51]). HRMS: C
12
H
24
O
5
S requires
m/z [M+NH
4
]+ 298.1688; observedm/z 298.1661.
3.4. (1,10-Phenanthrolin-5-yl)-1-thio-𝛽-D-glucopyranoside
(2g) [27]. 1-Thio-𝛽-D-glucopyranose sodium salt 3 (65mg,
0.30mmol) in dry ethanol (2mL) was added to a solution
of 5,6-epoxy-5,6-dihydro-1,10-phenanthroline (50mg,
0.255mmol) in dry ethanol (2mL) and stirred at room temp-
erature for 36 h until complete conversion of the epoxide
as monitored by TLC (silica gel, EtOAc/CH
3
OH/NH
4
OH
7 : 3 : 1). The precipitate was collected and recrystalized from
EtOH affording a yellowish solid product (61mg, 64%):
mp 154-155∘C; [𝛼]
𝐷
24 −64.0∘ (c 0.38, DMSO). 1H NMR
(DMSO): 3.08 (t, J = 9.2Hz; H4), 3.17 (dd, J = 9.6, 8.8Hz;
H2), 3.23 (t, J = 8.7Hz; H3), 3.30 (ddd, J = 9.6, 6.5, 2.0Hz;
H5), 3.41 (dd, J = 11.8, 6.4Hz; H6), 3.69 (dd, J = 11.8, 1.9Hz;
H6), 4.79 (d, J = 9.7Hz; H1), 7.74 (dd, J = 8.1, 4.3Hz; H8󸀠),
7.80 (dd, J = 8.3, 4.2Hz; H3󸀠), 8.29 (s, H6󸀠), 8.36 (dd, J =
8.1, 1.6Hz; H4󸀠), 8.79 (dd, J = 8.4, 1.6Hz; H7󸀠), 9.02 (dd, J =
4.3, 1.6Hz; H9󸀠), 9.09 (dd, J = 4.2, 1.6Hz; H2󸀠). 13C NMR
(DMSO): 61.57 (C6), 70.36 (C4), 73.17 (C2), 79.74 (C3), 81.75
(C5), 87.46 (C1), 123.91 (C3󸀠), 124.29 (C8󸀠), 128.73, 128.82
(C4a󸀠/C6a󸀠), 129.13 (C6󸀠), 131.44 (C5󸀠), 134.13 (C4󸀠), 136.34
(C7󸀠), 145.20, 145.86 (C10a󸀠/C10b󸀠), 150.48, 150.55 (C2󸀠/C9󸀠).
HRMS: C
30
H
26
N
4
O
2
S
2
requires m/z [M+H]+ 375.1015;
observedm/z 375.1022.
3.5. Diethyl 7-oxabicyclo[4.1.0]heptane-trans-3,4-dicarboxyl-
ate (4). The epoxide 4 was prepared as described before [25]
and isolated by column chromatography (Al
2
O
3
, gradient
washing with hexane/EtOAc 8 : 2 → 7 : 3) as a colorless liquid
(60%). 1H NMR (CDCl
3
): 𝛿 1.21 (t, J = 7.1Hz, 3H; CH
3
), 1.22
(t, J = 7.1Hz, 3H; CH
3
), 1.87 (ddd, J = 14.9, 10.8, 2.1 Hz; H2),
2.04 (dd, J = 15.5, 10.9Hz; H5), 2.30 (ddd, J = 15.5, 6.6, 4.8Hz;
H5), 2.45 (ddd, J = 14.9, 4.8, 1.8Hz; H2), 2.58 (dt, J = 10.7,
6.7Hz; H4), 2.80 (dt, J = 10.7, 4.9Hz; H3), 3.17 (t, J = 4.3Hz;
H6), 3.24 (m, H1), 4.11 (m, 4H; OCH
2
). 13C NMR (CDCl
3
):
𝛿 14.20 (CH
3
), 26.44 (C5), 27.30 (C2), 37.80 (C3), 40.14 (C4),
50.40 (C6), 52.00 (C1), 60.84 (OCH
2
), 173.76, 174.82 (C=O).
HRMS: C
12
H
18
O
5
requires [M+H]+ m/z 243.1233; observed
m/z 243.1240.
3.6. [(1S∗,2S∗,4S∗,5S∗)-2-Hydroxy-4,5-bis(ethoxycarbonyl)-
cyclohexyl]-1-thio-𝛽-D-glucopyranoside (2h). 1-Thio-𝛽-D-gl-
ucopyranose sodium salt 3 (100mg, 0.46mmol) in 7mL of
ethanol was added to a suspension of epoxide 4 (80mg,
0.33mmol) in ethanol (2mL) at room temperature. Reac-
tion mixture was stirred at 40∘C for 12 h until complete
conversion of the epoxide as monitored by TLC (silica
gel, EtOAc/MeOH 4 : 1). The solvent was evaporated under
vacuum and residue was purified by column chromatogra-
phy (silica gel, EtOAc/MeOH 7 : 3) affording product 2h (a
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mixture of diastereomers 1 : 1) as a white solid (55mg, 38%).
1H NMR (CD
3
OD): 𝛿 1.21 (t, J = 7.1Hz, 6H; 2CH
3
), 1.89 (dd,
J = 8.3, 3.4Hz, 1H; H3󸀠); 1.94−2.05 (m, 2H; H3󸀠+H6󸀠), 2.21,
2.24 (dt, J = 3.9, 11.6Hz, 1H; H6󸀠), 2.86, 2.89 (dt, J = 3.7,
11.3Hz; H4󸀠), 2.98 (m, H5󸀠), 3.17 (t, J = 8.6Hz; H2), 3.23–3.35
(m, 4H; H1󸀠+H3+H4+H5), 3.62, 3.65 (dd, J = 12.1, 5.1 Hz, 1H;
H6), 3.84 (dd, J = 12.1, 1.8Hz, 1H; H6), 3.98, 4.02 (br dd, J =
6.4, 3.3Hz; H2󸀠), 4.06–4.14 (m, 4H; OCH
2
), 4.41, 4.42 (d, J =
9.8Hz; H1). 13C NMR (CD
3
OD): 𝛿 13.14 (CH
3
), 28.51, 28.92
(C6󸀠), 30.29, 30.45 (C3󸀠), 39.09, 39.14 (C5󸀠), 40.22, 40.24 (C4󸀠),
44.34, 44.89 (C1󸀠), 60.53, 60.58 (OCH
2
), 61.53 (C6), 67.73,
68.36 (C2󸀠), 69.92, 70.01 (C4), 73.12, 73.18 (C2), 78.21 (C3),
80.77 (C5), 85.91, 86.00 (C1), 174.88, 175.18 (C=O). HRMS:
C
18
H
30
O
10
S requires m/z [M+NH
4
]+ 456.1903, [M+H]+
439.1638; observedm/z 456.1967, 439.1654.
3.7. [(1S∗,2S∗,4S∗,5S∗)-2-Hydroxy-4,5-bis (hydroxycarbonyl)-
cyclohexyl]-1-thio-𝛽-D-glucopyranoside (2i). 1mL of KOH
(1M) was added to a solution of diester 2h (150mg,
0.34mmol) in 2mL of methanol and mixture stirred for
72 h at room temperature. HCl (1M) was added to reaction
mixture till pH 6 and solvent was evaporated under vacuum.
Residue was purified by column chromatography (silica gel,
EtOAc/CH
3
OH 1 : 4) affording product 2i (one diastereomer)
as a white solid (40mg, 31%; mp > 240∘C). 1H NMR
(CD
3
OD): 𝛿 1.85 (dd, J = 13.4, 3.8Hz; H3󸀠), 1.93–2.05 (m, 2H;
H6󸀠+H3󸀠), 2.26 (m, 1H; H6󸀠), 2.85 (m, H5󸀠), 2.95 (m, H4󸀠),
3.19 (t, J = 9.1Hz; H2), 3.21–3.35 (m, 4H; H1󸀠+H3+H4+H5),
3.64 (m, 1H; H6), 3.84 (m, 1H; H6), 3.95 (m, H2󸀠), 4.43 (d,
J = 9.8Hz; H1). 13C NMR (CD
3
OD): 𝛿 29.23 (C6󸀠), 29.66
(C3󸀠), 31.02 (C4󸀠), 31.18 (C5󸀠), 48.53 (C1󸀠), 61.46 (C6), 69.05
(C2󸀠), 69.98 (C4), 73.17 (C2), 78.24, 80.72 (C3/C5), 85.99 (C1),
179.73 (C=O). HRMS: C
14
H
22
O
10
S requires m/z [M+NH
4
]+
400.1277; observedm/z 400.1289.
3.8. Procedures for the Glycosidase Inhibition and Activation
Assay. Theenzyme activities (𝛼/𝛽-D-galactosidases and𝛼/𝛽-
D-glucosidases) were assayed using multienzyme complexes
isolated from fungi P. canescens and A. oryzae as described
before [25–27]. All assays were performed in a standard
way by monitoring spectrophotometrically (with Beckman
Du-65 spectrometer) the release of p-nitrophenol from the
corresponding p-nitrophenyl glycosides at 30∘C. One unit of
enzyme activity was defined as the amount of enzyme that
releases 1 𝜇mol of p-nitrophenol per minute. Enzyme and
substrate concentrations were selected so that the degree of
hydrolysis was never more than 20% and in most cases was
less than 10%, over the course of the assay. The method used
tomeasure the rate of the reaction assumes that the amount of
the substrate is high enough, such that the disappearance over
a given period is insignificant; that is, the rate of the reaction
is close to linear for the first stage of the reaction.
For the preliminary estimation, the enzyme solutions
(100 𝜇L with activities 750 ± 150 𝜇U) were mixed with a
set of inhibitor/activator solutions (100 𝜇L, 10mM) and then
diluted with 700 𝜇L of 0.2M acetic buffer (pH 4.2), and the
mixture was incubated for 1 h at 30∘C. The reaction was
initiatedwith addition of a proper substrate (100 𝜇L of 20mM
p-nitrophenyl glycopyranoside), and aliquotswere taken after
5 and 10min. The reaction was terminated by addition of
1mL of 1M Na
2
CO
3
to 0.5mL of aliquot solution. The
concentration of the released p-nitrophenol was determined
at 400 nmusingmolar extinction coefficient 18.3mM−1 cm−1.
The inhibition/activation was estimated as a loss/increase of
enzymatic activity in % (Figures 1 and 2).
The same protocol was used for estimation of the kinetic
parameters with the following changes: 1mL of enzyme
solution, 0.5mL inhibitor solution, and 3.0mL of 0.2M acetic
buffer (pH 4.2) were incubated for 1 h at 30∘C before addition
of 0.5mL of substrate (20mM). Six substrate solutions
were prepared with various concentrations up to saturation
point for each enzyme. The final substrate concentration
after all additions varied from 0.01mM to 2.00mM. The
final inhibitor concentrations were 330𝜇M for A. oryzae
and 33 𝜇M for P. canescens. Reaction rates were measured
as described above. Control experiments with no enzyme
were performed to exclude the errors due to the substrate
spontaneous hydrolysis. Enzyme behavior (at pH 4.2 and
30∘C) abided theMichaelis-Menten equation. Parameters𝐾
𝑀
and 𝐾
𝑀
app were calculated from Lineweaver-Burk (double-
reciprocal) plot [52, 53].The𝐾
𝑀
values were used to calculate
𝐾
𝑖
by the following equation:
𝐾
𝑖
=
𝐾
𝑀 [𝐼]
(𝐾
𝑀
app − 𝐾
𝑀
)
. (1)
Three independent trials using freshly prepared substrate and
enzyme solutions were performed to obtain each parameter.
Values for 𝐾
𝑀
were reproducible within ±5% and ±10%,
respectively, and the standard error was ±15% for the 𝐾
𝑖
values (Table 1).
4. Conclusions
The results of our studies show that simple and readily avail-
able 1-thio-𝛽-D-glucopyranosides can be potent inhibitors
for 𝛼- and 𝛽-D-glucosidases. The efficiency of inhibition
strongly depends on the structure of aglycon and generally
increases for 𝛽-glucosidases with increase of its lipophilicity.
Another interesting feature of the studied compounds is an
activation of 𝛼- and 𝛽-galactosidases.
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